自从1975年发现了单克隆抗体技术和不久后提出生物导弹设想以来，导向治疗受到许多科研工作者的关注。
Since 1975 when the technology of hybridoma and monoclonal antibody was developed, many investigators have been paying close attention to antibody targeting therapy for patients with cancer.
利用免疫毒素进行导向治疗是生物治疗的一个重要途径。
One strategy for targeted cancer biotherapy is to utilize recombinant immunotoxins.
应用推荐